The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Real-world treatment patterns of Bruton tyrosine kinase inhibitors (BTKi) in patients with mantle cell lymphoma (MCL) in community oncology practices in the United States (US).
 
Bijal D. Shah
Honoraria - BeiGene; Gilead Sciences; Pharmacyclics/Janssen; Spectrum/Acrotech
Consulting or Advisory Role - Adaptive Biotechnologies; Amgen; Autolus; Bristol-Myers Squibb/Celgene; Century Therapeutics; Deciphera; Jazz Pharmaceuticals; Kite, a Gilead company; Lilly; Novartis; Pepromene; Pfizer; Pfizer; Precision Biosciences
Research Funding - Incyte; Jazz Pharmaceuticals (Inst); Kite/Gilead (Inst); SERVIER (Inst)
Travel, Accommodations, Expenses - AstraZeneca; Celgene; Janssen; Kite, a Gilead company; Novartis; Pfizer; Seagen; Stemline Therapeutics
 
Mei Xue
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene
Research Funding - BeiGene
 
Keri Yang
Employment - BeiGene
Leadership - BeiGene
Stock and Other Ownership Interests - BeiGene
Research Funding - BeiGene
Travel, Accommodations, Expenses - BeiGene
 
Sizhu Liu
Employment - BeiGene; GlaxoSmithKline
 
Boxiong Tang
Employment - BeiGene
Stock and Other Ownership Interests - BeiGene